Nu Holdings Stock Drop Reflects U.S. Expansion Jitters Despite Solid Earnings

What happened

Nu Holdings reported strong Q4 2025 earnings in late February, with revenue up 45% YoY and net income increasing 50%. Despite the solid performance, the stock declined 15.6% in February as investors grew uncertain about the company's U.S. expansion plans, as highlighted in the news article. The DeepValue report confirms that the conditional OCC approval for a U.S. national bank has stringent deadlines, requiring $504 million in capital within 12 months and bank opening within 18 months from January 29, 2026. This uncertainty raises execution risks, threatening the 'U.S. optionality' narrative that has supported the stock's premium valuation. The market's reaction underscores the tension between Nu's current profitability in Brazil and the high-stakes regulatory hurdles in its expansion efforts.

Implication

The stock's decline signals a shift in market focus from growth optimism to execution risk, particularly around the U.S. charter's conditional approval and deadlines. Nu's elevated valuation at 25.4x P/E offers no margin of safety, making any delays in U.S. milestones a direct threat to shareholder returns. As per the DeepValue report, investors must closely monitor Q1 2026 results for ARPAC growth above $15 and efficiency ratio stability near 20%, with failures potentially breaking the investment thesis. Lack of visible progress on FDIC/Fed approvals by mid-2026 could derail the U.S. expansion, necessitating a downgrade from the current 'WAIT' rating. Prudent action involves waiting for a pullback to the $13.50 attractive entry or proof that efficiency stays ≤21% with credit performance intact before considering new positions.

Thesis delta

The DeepValue report's 'WAIT' thesis remains unchanged, but the stock drop validates its emphasis on U.S. execution risks as a critical overhang. No fundamental shift is warranted yet, but investors should reinforce vigilance on the 90-day checkpoints for ARPAC, NPL, and efficiency metrics. Any deviation from these thresholds could accelerate a bear case, underscoring the need for patience until clearer regulatory progress emerges.